June 01, 2012 03:57 AM UTC

Corruption at the core of Obamacare?

•  
• by: Libertad

Saying this couldn’t come at a worse time is an understatement.

The depth and utter frankness of the corruption detailed below should be mindnumbing. Obama himself must address this issue directly.

The Democrat Congress and Senate, who passed Obamacare for Obama, must join the adminstration to come clean with other corruption or horrors embedded within Frank-Dodd, new EPA regulations, NLRB-union boss deals, etc…

One of PhRMA’s top goals was to prevent the new health care law from legalizing the reimportation of prescription drugs. It got its wish after making a secret deal with the White House, the progress of which is detailed in the newly released documents. Nancy DeParle, then-director of the White House Office of Health Reform, wrote to PhRMA’s chief lobbyist on June 3, 2009: “Yes — I pushed this to everyone (Messina, Rahm) is in Egypt with POTUS but Phil Schrillo, Dana Singlser and I made [the] decision, based on how constructive you guys have been, to oppose importation on this bill.“

Source: WashingtonExaminer and plenty of other media outlets

At the time, Rahm Emanuel was White House chief of staff, Jim Messina was deputy chief of staff, Phil Schrillo was Obama’s legislative affairs director and Dana Singlser was his special assistant to the president for legislative affairs.

As part of the final deal, PhRMA agreed to support health care legislation, spend millions on ads promoting it, and concede $80 billion in savings and taxes to help finance the bill. In exchange, PhRMA not only ended up with a law that promised to provide it with millions of new customers, but protected it against policies contemplated by Democrats that would have been harmful to their profits. In addition to preventing drug reimportation, the White House also blocked the government from negotiating lower drug prices in the Medicare prescription drug program — precisely what Obama had faulted Tauzin for doing from his perch in Congress.

That September, top PhRMA lobbyist Bryant Hall reported in an email that he “had a good call w [with] Messina” and wrote: “Confidential: WH is working on some very explicit language on importation to kill it in health care reform. This has to stay quiet.”



Drug reimportation never made it into the final legislation.

Source: WashingtonExaminer and plenty of other media outlets